Ovarian Cancer Detection in Ascites Cytology with Weakly Supervised Model on Nationwide Data Set.

Journal: The American journal of pathology
Published Date:

Abstract

Conventional ascitic fluid cytology for detecting ovarian cancer is limited by its low sensitivity. To address this issue, this multicenter study developed patch image (PI)-based fully supervised convolutional neural network (CNN) models and clustering-constrained attention multiple-instance learning (CLAM) algorithms for detecting ovarian cancer using ascitic fluid cytology. Whole-slide images (WSIs), 356 benign and 147 cancer, were collected, from which 14,699 benign and 8025 cancer PIs were extracted. Additionally, 131 WSIs (44 benign and 87 cancer) were used for external validation. Six CNN algorithms were developed for cancer detection using PIs. Subsequently, two CLAM algorithms, single branch (CLAM-SB) and multiple branch (CLAM-MB), were developed. ResNet50 demonstrated the best performance, achieving an accuracy of 0.973. The performance when interpreting internal WSIs was an area under the curve (AUC) of 0.982. CLAM-SB outperformed CLAM-MB with an AUC of 0.944 for internal WSIs. Notably, in the external test, CLAM-SB exhibited superior performance with an AUC of 0.866 compared with ResNet50's AUC of 0.804. Analysis of the heatmap revealed that cases frequently misinterpreted by AI were easily interpreted by humans, and vice versa. Because AI and humans were found to function complementarily, implementing computer-aided diagnosis is expected to significantly enhance diagnostic accuracy and reproducibility. Furthermore, the WSI-based learning in CLAM, eliminating the need for patch-by-patch annotation, offers an advantage over the CNN model.

Authors

  • Jiwon Lee
    Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Seonggyeong Choi
    College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Seoyeon Shin
    College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Mohammad Rizwan Alam
    Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Jamshid Abdul-Ghafar
    Department of Pathology and Clinical Laboratory, French Medical Institute for Mothers and Children (FMIC), Kabul, Afghanistan. jamshid.jalal@fmic.org.af.
  • Kyung Jin Seo
    Department of Hospital Pathology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Gisu Hwang
    AI Team, DeepNoid Inc., Seoul 08376, Republic of Korea.
  • Daeky Jeong
    AI Research Lab, DEEPNOID Inc., Seoul, South Korea.
  • Gyungyub Gong
    Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Nam Hoon Cho
    Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea. cho1988@yuhs.ac.
  • Chong Woo Yoo
    Department of Pathology, National Cancer Center, Ilsan, Goyang-si 10408, Gyeonggi-do, Republic of Korea.
  • Hyung Kyung Kim
    Department of Pathology, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea; Department of Pathology, Samsung Medical Center, Seoul, Republic of Korea.
  • Yosep Chong
    Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, Uijeongbu, 11765, Gyeonggi-do, Republic of Korea. ychong@catholic.ac.kr.
  • Kwangil Yim
    Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.